Literature DB >> 30533874

Complete Genome Sequence of Pseudomonas aeruginosa K34-7, a Carbapenem-Resistant Isolate of the High-Risk Sequence Type 233.

George Taiaroa1,2, Ørjan Samuelsen3,4, Tom Kristensen5, Ole Andreas Løchen Økstad6,7, Adam Heikal6,7.   

Abstract

Carbapenem-resistant Pseudomonas aeruginosa is defined as a "critical" priority pathogen for the development of new antibiotics. Here we report the complete genome sequence of an extensively drug-resistant, Verona integron-encoded metallo-β-lactamase-expressing isolate belonging to the high-risk sequence type 233.

Entities:  

Year:  2018        PMID: 30533874      PMCID: PMC6256419          DOI: 10.1128/MRA.00886-18

Source DB:  PubMed          Journal:  Microbiol Resour Announc        ISSN: 2576-098X


ANNOUNCEMENT

Carbapenem-resistant Pseudomonas aeruginosa is a critical threat to public health (1). P. aeruginosa K34-7 belongs to sequence type 233 (ST233) and is an extensively drug-resistant (XDR), carbapenem-resistant clinical isolate expressing the Verona integron-encoded metallo-β-lactamase (VIM-2) (2). ST233 has been identified as a high-risk clone in both Mexico (3) and the United States (4). K34-7 was the first metallo-β-lactamase-producing P. aeruginosa isolate identified in Norway, and PCR analysis previously confirmed that the blaVIM-2 gene was contained within an unusual class 1 integron (GenBank accession number FM165436) (2). As only one other P. aeruginosa ST233 complete genome has been published (5), this high-quality P. aeruginosa K34-7 genome will provide a valuable additional genomic resource for investigation of this high-risk ST. Genomic DNA was prepared from a culture grown from a single colony using the Mo Bio DNeasy UltraClean microbial kit (Qiagen, USA) and sequenced on a PacBio RS II platform. A standard library of 20-kb fragments was prepared using the BluePippin preparative electrophoresis system (Sage Science, USA) with a 9-kb cutoff and sequenced on a single-molecule real-time (SMRT) cell using P6-C4 chemistry with 360-min movie-time chemistry. Additional whole-genome sequencing (WGS) was performed using an Illumina HiSeq sequencer. Genome assembly involved a de novo approach, using default HGAP 4 settings for the assembly of 96,269 PacBio reads (average length, 10,760 bp), before manual curation and validation. Iterative read mapping of Illumina sequences using custom settings in Geneious 10.1.3 (6) was used to identify assembly errors, primarily single-base insertions and deletions, and for variant correction (0.7 minimum variant frequency, 5× minimum coverage). Custom settings included allowed gaps (15% maximum/read and 15-bp maximum size); word and index word lengths of 18 and 13, respectively; and 20% maximum mismatch/read and maximum ambiguity of 4. The K34-7 genome consists of a 7,038,012-bp chromosome and one plasmid, pK34-7-1 (4,440 bp). A P. aeruginosa genomic island 5 (PAGI-5)-like hybrid (7) pathogenicity island (84,893 bp) and bacteriophage (38,832 bp) were found on the chromosome (positions 4154015 to 4238618 and 6469185 to 6508016, respectively). The XDR K34-7 phenotype is predominantly due to genes associated with three chromosomally located class 1 integrons, including genes imparting resistance to aminoglycosides [aac(3), aac(3)-I, aac(6´)-Il, aadA2, and aph(3´)-IIb], β-lactams (blaOXA-4, blaOXA-486, blaPDC-3, and blaVIM-2), chloramphenicol (catB, cmlA6, and floR), trimethoprim (dfrB5), fosfomycin (fosA), sulfonamide (sul1), and tetracycline (tetG), as annotated by the PGAP pipeline (8). Additionally, tetK, encoding the tetracycline efflux pump TetK, is found on the small pK34-7-1 plasmid. A region (1936000 to 2043700) of 12 direct tandem repeats (7,122 bp, 11.5× mean Illumina coverage) encodes a zonular occludens toxin, previously characterized in Vibrio cholerae (9, 10). Similar regions appear in other P. aeruginosa genomes but not in the ST233 P. aeruginosa PA83 genome (5). Additionally, P. aeruginosa K34-7 contains a type I-F CRISPR-Cas system (1656563 to 1664702), previously described in P. aeruginosa strain UCBPP-PA14 (11). Complete high-quality bacterial genomes facilitate further research into mechanisms of resistance and their dissemination and aid in the development of new therapies for XDR infections.

Data availability.

This complete genome project has been deposited at GenBank under the accession numbers CP029707 and CP029708.
  10 in total

1.  Zonula occludens toxin structure-function analysis. Identification of the fragment biologically active on tight junctions and of the zonulin receptor binding domain.

Authors:  M Di Pierro; R Lu; S Uzzau; W Wang; K Margaretten; C Pazzani; F Maimone; A Fasano
Journal:  J Biol Chem       Date:  2001-02-14       Impact factor: 5.157

2.  Rapid and Consistent Evolution of Colistin Resistance in Extensively Drug-Resistant Pseudomonas aeruginosa during Morbidostat Culture.

Authors:  Bianca Dößelmann; Matthias Willmann; Matthias Steglich; Boyke Bunk; Ulrich Nübel; Silke Peter; Richard A Neher
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

3.  Zonula occludens toxin as a new promising adjuvant for mucosal vaccines.

Authors:  Maria Teresa De Magistris
Journal:  Vaccine       Date:  2006-04-12       Impact factor: 3.641

4.  The first metallo-beta-lactamase identified in norway is associated with a TniC-like transposon in a Pseudomonas aeruginosa isolate of sequence type 233 imported from Ghana.

Authors:  Orjan Samuelsen; Liselotte Buarø; Mark A Toleman; Christian G Giske; Nils O Hermansen; Timothy R Walsh; Arnfinn Sundsfjord
Journal:  Antimicrob Agents Chemother       Date:  2008-11-17       Impact factor: 5.191

5.  Requirements for Pseudomonas aeruginosa Type I-F CRISPR-Cas Adaptation Determined Using a Biofilm Enrichment Assay.

Authors:  Gary E Heussler; Jon L Miller; Courtney E Price; Alan J Collins; George A O'Toole
Journal:  J Bacteriol       Date:  2016-10-21       Impact factor: 3.490

6.  Hybrid pathogenicity island PAGI-5 contributes to the highly virulent phenotype of a Pseudomonas aeruginosa isolate in mammals.

Authors:  Scott E Battle; Folker Meyer; Jordi Rello; Vanderlene L Kung; Alan R Hauser
Journal:  J Bacteriol       Date:  2008-08-29       Impact factor: 3.490

7.  Extensively drug-resistant pseudomonas aeruginosa isolates containing blaVIM-2 and elements of Salmonella genomic island 2: a new genetic resistance determinant in Northeast Ohio.

Authors:  Federico Perez; Andrea M Hujer; Steven H Marshall; Amy J Ray; Philip N Rather; Nuntra Suwantarat; Donald Dumford; Patrick O'Shea; T Nicholas J Domitrovic; Robert A Salata; Kalyan D Chavda; Liang Chen; Barry N Kreiswirth; Alejandro J Vila; Susanne Haussler; Michael R Jacobs; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2014-07-28       Impact factor: 5.191

8.  Geneious Basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data.

Authors:  Matthew Kearse; Richard Moir; Amy Wilson; Steven Stones-Havas; Matthew Cheung; Shane Sturrock; Simon Buxton; Alex Cooper; Sidney Markowitz; Chris Duran; Tobias Thierer; Bruce Ashton; Peter Meintjes; Alexei Drummond
Journal:  Bioinformatics       Date:  2012-04-27       Impact factor: 6.937

9.  Identification of extensive drug resistant Pseudomonas aeruginosa strains: New clone ST1725 and high-risk clone ST233.

Authors:  Pamela Aguilar-Rodea; Gerardo Zúñiga; Benjamín Antonio Rodríguez-Espino; Alma Lidia Olivares Cervantes; Ana Estela Gamiño Arroyo; Sarbelio Moreno-Espinosa; Daniela de la Rosa Zamboni; Briceida López Martínez; María Del Carmen Castellanos-Cruz; Israel Parra-Ortega; Verónica Leticia Jiménez Rojas; Juan Carlos Vigueras Galindo; Norma Velázquez-Guadarrama
Journal:  PLoS One       Date:  2017-03-02       Impact factor: 3.240

10.  NCBI prokaryotic genome annotation pipeline.

Authors:  Tatiana Tatusova; Michael DiCuccio; Azat Badretdin; Vyacheslav Chetvernin; Eric P Nawrocki; Leonid Zaslavsky; Alexandre Lomsadze; Kim D Pruitt; Mark Borodovsky; James Ostell
Journal:  Nucleic Acids Res       Date:  2016-06-24       Impact factor: 16.971

  10 in total
  4 in total

1.  Molecular Characterization of Multidrug-Resistant Pseudomonas aeruginosa Isolates in Hospitals in Myanmar.

Authors:  Tatsuya Tada; Tomomi Hishinuma; Shin Watanabe; Hiroki Uchida; Mari Tohya; Kyoko Kuwahara-Arai; San Mya; Khin Nyein Zan; Teruo Kirikae; Htay Htay Tin
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

2.  Genomic Characterization of Mutli-Drug Resistant Pseudomonas aeruginosa Clinical Isolates: Evaluation and Determination of Ceftolozane/Tazobactam Activity and Resistance Mechanisms.

Authors:  Ibrahim Bitar; Tamara Salloum; Georgi Merhi; Jaroslav Hrabak; George F Araj; Sima Tokajian
Journal:  Front Cell Infect Microbiol       Date:  2022-06-15       Impact factor: 6.073

3.  Whole Genome Sequencing of Ceftolozane-Tazobactam and Ceftazidime-Avibactam Resistant Pseudomonas aeruginosa Isolated from a Blood Stream Infection Reveals VEB and Chromosomal Metallo-Beta Lactamases as Genetic Determinants: A Case Report.

Authors:  Aisha M Alamri; Somayah Alfifi; Yasser Aljehani; Amani Alnimr
Journal:  Infect Drug Resist       Date:  2020-11-23       Impact factor: 4.003

4.  Nucleotide substitutions in the mexR, nalC and nalD regulator genes of the MexAB-OprM efflux pump are maintained in Pseudomonas aeruginosa genetic lineages.

Authors:  Pamela Aguilar-Rodea; Gerardo Zúñiga; René Cerritos; Benjamín Antonio Rodríguez-Espino; Uriel Gomez-Ramirez; Carolina G Nolasco-Romero; Beatriz López-Marceliano; Gerardo E Rodea; Sandra Mendoza-Elizalde; Alfonso Reyes-López; Héctor Olivares Clavijo; Juan Carlos Vigueras Galindo; Norma Velázquez-Guadarrama; Irma Rosas-Pérez
Journal:  PLoS One       Date:  2022-05-10       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.